At the annual meeting of the European Association for the Study of Diabetes (EASD) in September, clinical trial results published in The Lancet showed that tirzepatide, sold under the brand name Mounjaro, significantly improved glycemic control and weight management in children and adolescents with type 2 diabetes, most of whom had responded poorly to existing […]